Quick Takeaways
- VANGUARD GROUP INC filed SCHEDULE 13G/A for Elevation Oncology Inc Common Stock (ELEV).
- Disclosed ownership: 4.4%.
- Date of event: 31 Dec 2024.
VANGUARD GROUP INC - 31 Dec 2024 SCHEDULE 13G/A Report for Elevation Oncology Inc Common Stock (ELEV)
- Filing Manager
- VANGUARD GROUP INC
- Reporting Manager
- The Vanguard Group
- Security
- Elevation Oncology Inc Common Stock
- Symbol
- ELEV
- Shares outstanding
- 59,184,694 shares
- Disclosed Ownership
- 2,610,045 shares
- Ownership
- 4.4%
- Form type
- SCHEDULE 13G/A
- Filing time
- 30 Jan 2025, 21:33:44 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"VANGUARD GROUP INC disclosed 4.4% ownership in Elevation Oncology Inc Common Stock (ELEV) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 Jan 2025, 21:33.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Vanguard Group | 4.4% | 2,610,045 | 0 | 60,449 | Ashley Grim | Head of Global Fund Administration |